ZA200704735B - Use of tyrosine kinase inhibitors for the treatment of chronic rhinosinusitis - Google Patents

Use of tyrosine kinase inhibitors for the treatment of chronic rhinosinusitis

Info

Publication number
ZA200704735B
ZA200704735B ZA200704735A ZA200704735A ZA200704735B ZA 200704735 B ZA200704735 B ZA 200704735B ZA 200704735 A ZA200704735 A ZA 200704735A ZA 200704735 A ZA200704735 A ZA 200704735A ZA 200704735 B ZA200704735 B ZA 200704735B
Authority
ZA
South Africa
Prior art keywords
treatment
tyrosine kinase
kinase inhibitors
chronic rhinosinusitis
rhinosinusitis
Prior art date
Application number
ZA200704735A
Inventor
Jung Birgit
Disse Bernd
Pohl Gerald
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA200704735B publication Critical patent/ZA200704735B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
ZA200704735A 2005-02-04 2007-06-15 Use of tyrosine kinase inhibitors for the treatment of chronic rhinosinusitis ZA200704735B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005005505A DE102005005505A1 (en) 2005-02-04 2005-02-04 Use of quinazoline derivatives e.g. 4-((3-chloro-4-fluoro-phenyl)amino)-6-(1-methanesulfonyl-piperidin-4-yloxy)-7-methoxy-quinazoline, which are tyrosine kinase inhibitors, to prevent or treat symptoms of e.g. chronic rhinosinusitis

Publications (1)

Publication Number Publication Date
ZA200704735B true ZA200704735B (en) 2008-09-25

Family

ID=36709736

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200704735A ZA200704735B (en) 2005-02-04 2007-06-15 Use of tyrosine kinase inhibitors for the treatment of chronic rhinosinusitis

Country Status (3)

Country Link
CN (1) CN101115485A (en)
DE (1) DE102005005505A1 (en)
ZA (1) ZA200704735B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102838590B (en) * 2011-06-21 2014-07-09 苏州迈泰生物技术有限公司 Amino quinazoline derivative and application thereof in preparation of antineoplastic drugs
CN102633812B (en) * 2012-04-06 2014-11-12 中国药科大学 Oxazolone quinazoline derivatives as well as preparation method and application thereof
CN103724351A (en) * 2012-10-11 2014-04-16 韩冰 Compound for treating cerebral palsy and use thereof
CN103804353A (en) * 2012-11-01 2014-05-21 常辉 Compounds for treatment of schizophrenia and their use

Also Published As

Publication number Publication date
CN101115485A (en) 2008-01-30
DE102005005505A1 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
HK1222124A1 (en) Inhibitors of brutons tyrosine kinase for the treatment of solid tumors
EP2040546A4 (en) Tyrosine kinase inhibitors
IL190935A0 (en) 4-(3-aminopyrazole)pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
HK1129890A1 (en) C-met protein kinase inhibitors for the treatment of proliferative disorders
IL186845A0 (en) Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
SI2120932T1 (en) Indazole derivatives as kinase inhibitors for the treatment of cancer
ZA200606152B (en) 2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors
IL195152A0 (en) Use of syk tyrosine kinase inhibitors for the treatment of cell proliferative disorders
EP1753428A4 (en) Kinase inhibitors as therapeutic agents
ZA200900019B (en) Tyrosine kinase inhibitors
HK1145496A1 (en) Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
EP1968950A4 (en) Pyrimidine kinase inhibitors
HK1145495A1 (en) Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
HK1114380A1 (en) Pyrrolopyrazoles as kinase inhibitors
IL177278A0 (en) Pyrazolotriazines as kinase inhibitors
IL190078A0 (en) Kinase inhibitors
ZA200709269B (en) Protein kinase inhibitors
PL1943243T3 (en) Kinase inhibitors
IL184997A0 (en) Use of tyrosine kinase inhibitors for the treatment of chronic rhinosinusitis
IL187895A0 (en) Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
EP1951252A4 (en) Tyrosine kinase inhibitors
IL184798A0 (en) Quinazoline derivatives as tyrosine kinase inhibitors
ZA200608998B (en) Imidazole derivatives as tyrosine kinase inhibitors
ZA200704735B (en) Use of tyrosine kinase inhibitors for the treatment of chronic rhinosinusitis
ZA200710136B (en) Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met